QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 kiora-pharmaceuticals-joins-global-genes-rare-x-vision-consortium-a-corporate-nonprofit-initiative-aimed-at-advancing-research-for-rare-ocular-disorders

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) and Global Genes today announced that Kiora has joined Global Genes' RARE-X Visio...

 kiora-pharmaceuticals-files-for-100m-mixed-shelf-offering

https://www.sec.gov/Archives/edgar/data/1372514/000137251425000072/s-3xseptember2025.htm

 hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price ta...

 kiora-pharmaceuticals-granted-us-patent-expanding-protection-for-kio-104-in-the-treatment-of-ocular-disease

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) today announced it has received a patent (US Patent No. 12,364,680) covering KIO-104 ...

 kiora-grants-senju-option-to-develop-and-market-vision-restoring-drug-kio-301-in-asia

Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) ("Kiora" or the "Company") today announced it has granted Senju Pharm...

 hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price ta...

 hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price ta...

 hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-10-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $10 price ta...

 hc-wainwright--co-maintains-buy-on-kiora-pharmaceuticals-adjusts-price-target-to-10-1-9-reverse-stock-split

HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy, adjusts target to $10 from $2...

 hc-wainwright--co-reiterates-buy-on-kiora-pharmaceuticals-maintains-2-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and maintains $2 price tar...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION